VanEck Genomics and Healthcare Innovators UCITS ETF

The VanEck Genomics and Healthcare Innov ETF invests in a diverse range of companies that are leading advancements in genomics, biotechnology, medical devices, and digital health technologies. Launched in September 2022, the fund focuses on firms involved in genetic research, personalized medicine, and the integration of electronic systems in healthcare. By tracking the MVISGlobal Future Healthcare ESG Index, the ETF includes innovators driving breakthroughs in areas like genetic therapies and electronic healthcare solutions, offering investors exposure to the cutting-edge sectors shaping the future of healthcare.